Related Experiment Videos

p53: Multiple Facets of a Rubik's Cube

Yun Zhang1, Guillermina Lozano1

  • 1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.

Insights

This review explores the p53 tumor suppressor, detailing wild-type functions, regulation by murine double minute proteins, and tissue-specific activities. It highlights mutant p53 gain-of-function activities and stabilization mechanisms in cancer.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The p53 tumor suppressor is a critical regulator of cell fate, involved in cell survival and death pathways.
  • Decades of research have elucidated many p53 functions, yet significant questions remain regarding its complex roles.
  • Negative regulators, such as the murine double minute (MDM) protein family, play crucial roles in p53 regulation.

Purpose of the Study:

  • To review the current understanding of wild-type p53 functions and regulation.
  • To summarize tissue-, stress-, and age-specific p53 activities and their underlying mechanisms.
  • To explore the gain-of-function activities and stabilization mechanisms of mutant p53 in human cancers.

Main Methods:

  • Literature review of existing research on p53.
  • Analysis of p53 gene alterations in human cancers, focusing on missense mutations.
  • Examination of experimental model systems and contexts to identify mutant p53 activities.

Main Results:

  • Wild-type p53 functions in cell survival/death and regulation are detailed, with emphasis on MDM proteins.
  • p53 activities show variations across different tissues, stress conditions, and ages.
  • p53 missense mutations are predominant in cancers, exhibiting gain-of-function activities by modifying gene transcription indirectly.
  • Mechanisms stabilizing mutant p53 are summarized, crucial for its oncogenic functions.

Conclusions:

  • Understanding wild-type and mutant p53 pathways is key to identifying cancer vulnerabilities.
  • Mutant p53's ability to retain transcriptional modification capabilities, despite alterations, is a significant finding.
  • Targeting the stabilization pathways of mutant p53 may offer therapeutic opportunities in cancer treatment.

Related Concept Videos